Industry News

  • 9 July 2019

    Addex to lead mGlu7 NAM-focused PTSD consortium

    Swiss-headquartered Addex Therapeutics has announced it will lead a consortium to develop small molecule negative allosteric modulators (NAMs) indicated to reduce fear memory in post-traumatic stress disorder (PTSD).

  • 21 June 2019

    NICE recommends NHS use of Alimera’s Iluvien for NIPU

    The UK’s drug pricing regulator the National Institutes of Health and Care Excellence (NICE) has recommended Alimera Sciences’ Iluvien (fluocinolone acetonide) for NHS patients with recurrent non-infectious posterior uveitis (NIPU).


Go Top